Millennium Management
CAPR icon

Millennium Management’s Capricor Therapeutics CAPR Stock Holding History

Millennium Management’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-200,500
Closed -$1.45M – 6040
2025
Q3 		$1.45M Buy
200,500
+160,500
+401% +$1.18M ﹤0.01% 4335
2025
Q2 		$397K Buy
+40,000
New +$423K ﹤0.01% 5049
2024
Q4 		– Sell
-24,100
Closed -$367K – 5983
2024
Q3 		$367K Buy
+24,100
New +$119K ﹤0.01% 5064

Other funds holding CAPR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Millennium Management's CAPR Position: Q1 2026 in Review

Millennium Management reduced its Capricor Therapeutics (CAPR) stake by 48% in Q1 2026, selling an estimated $8.69M and leaving 356,354 shares worth $10.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2096.

Millennium Management first reported a position in CAPR in Q1 2015 and has held it in 22 quarters since. The position peaked at $19.7M in Q4 2025. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • Millennium Management held 356,354 shares of Capricor Therapeutics worth $10.8M as of Q1 2026.
  • Millennium Management sold 325,990 Capricor Therapeutics shares in Q1 2026, an estimated $8.69M.
  • Capricor Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2096 holding.
  • Millennium Management first reported a position in Capricor Therapeutics in Q1 2015 and has held it in 22 quarters since.
  • Millennium Management's Capricor Therapeutics position peaked at $19.7M in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.